Mucin inhibition of lymphocyte function does not require specific mucin- ligand interactions

Scandinavian Journal of Immunology

Volumn 52, Issue 1, 2000, Pages 46-52

  Boyle, K P ^b   Chen, T ^a   Kozlowski, S ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Our Lady of Mercy Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MONOCLONAL ANTIBODY; MUCIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL INTERACTION; CELL SURFACE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; LEUKOCYTE ADHERENCE INHIBITION; LIGAND BINDING; LYMPHOCYTE PROLIFERATION; LYMPHOMA CELL LINE; MOUSE; MUCINOUS CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; SUBMANDIBULAR GLAND; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD3; CELL ADHESION; FEMALE; INTERCELLULAR ADHESION MOLECULE-1; LIGANDS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MUCINS; TUMOR CELLS, CULTURED;

EID: 0033920974     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00756.x     Document Type: Article

References (37)

1. 1 Van Klinken BJ, Dekker J, Buller HA, Einerhand AW. Mucin gene structure and expression: protection vs. adhesion. Am J Physiol 1995;269 (5 Part 1):G613-27.
2. 2 Halvorsen TB, Seim E. Influence of mucinous components on survival in colorectal adenocarcinomas: a multivariate analysis. J Clin Pathol 1988;41:1068-72.
3. 3 van der Merwe PA, McNamee PN, Davies EA, Barclay AN, Davis SJ. Topology of the CD2-CD48 cell-adhesion molecule complex: implications for antigen recognition by T cells. Curr Biol 1995;5:74-84.
4. 4 van de Wiel-van Kemenade E, Ligtenberg MJ, de Boer AJ et al. Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J Immunol 1993;151:767-76.
5. 5 Pilatte Y, Bignon J, Lambre CR. Sialic acids as important molecules in the regulation of the immune system: pathophysiological implications of sialidases in immunity. Glycobiology 1993;3:201-18.
6. 6 Agrawal B, Krantz MJ, Reddish MA, Longenecker BM. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nat Med 1998;4:43-9.
7. 7 Kam JL, Regimbald LH, Hilgers JH et al. MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats. Cancer Res 1998;58:5577-81.
8. 8 Gimmi CD, Morrison BW, Mainprice BA et al. Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells. Nat Med 1996;2:1367-70.
9. 9 Sperling AI, Sedy JR, Manjunath N, Kupfer A, Ardman B, Burkhardt JK. TCR signalling induces selective exclusion of CD43 from the T cell-antigen-presenting cell contact site. J Immunol 1998;161:6459-62.
10. 10 Bazil V, Strominger JL. CD43, the major sialoglycoprotein of human leukocytes, is proteolytically cleaved from the surface of stimulated lymphocytes and granulocytes. Proc Natl Acad Sci U S A 1993;90:3792-6.
11. 11 Nathan C, Xie QW, Halbwachs-Mecarelli L, Jin WW. Albumin inhibits neutrophil spreading and hydrogen peroxide release by blocking the shedding of CD43 (sialophorin, leukosialin). J Cell Biol 1993;122:243-56.
12. 12 Park JK, Rosenstein YJ, Remold-O'Donnell E, Bierer BE, Rosen FS, Burakoff SJ. Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome. Nature 1991;350:706-9.
13. 13 Sanchez-Mateos P, Campanero MR, del Pozo MA, Sanchez-Madrid F. Regulatory role of CD43 leukosialin on integrin-mediated T-cell adhesion to endothelial and extracellular matrix ligands and its polar redistribution to a cellular uropod. Blood 1995;86:2228-39.
14. 14 Mentzer SJ, Remold-O'Donnell E, Crimmins MA, Bierer BE, Rosen FS, Burakoff SJ. Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation. J Exp Med 1987;165:1383-92.
15. 15 Axelsson B, Youseffi-Etemad R, Hammarstrom S, Perlmann P. Induction of aggregation and enhancement of proliferation and IL-2 secretion in human T cells by antibodies to CD43. J Immunol 1988;141:2912-7.
16. 16 McFarland TA, Ardman B, Manjunath N, Fabry JA, Lieberman J. CD43 diminishes susceptibility to T lymphocyte-mediated cytolysis. J Immunol 1995;154:1097-104.
17. 17 Manjunath N, Correa M, Ardman M, Ardman B. Negative regulation of T-cell adhesion and activation by CD43. Nature 1995;377:535-8.
18. 18 Stockton BM, Cheng G, Manjunath N, Ardman B, von Andrian UH. Negative regulation of T cell homing by CD43. Immunity 1998;8:373-81.
19. 19 Baum LG, Pang M, Perillo NL et al. Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. J Exp Med 1995;181:877-87.
20. 20 Rosenstein Y, Park JK, Hahn WC, Rosen FS, Bierer BE, Burakoff SJ. CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1. Nature 1991;354:233-5.
21. 21 Stockl J, Majdic O, Kohl P, Pickl WF, Menzel JE, Knapp W. Leukosialin (CD43)-major histocompatibility class I molecule interactions involved in spontaneous T cell conjugate formation. J Exp Med 1996;184:1769-79.
22. 22 Walker J, Green JM. Structural requirements for CD43 function. J Immunol 1999;162:4109-14.
23. 23 Yonemura S, Hirao M, Doi Y et al. Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxtamembrane cytoplasmic domain of CD44, CD43, and ICAM-2. J Cell Biol 1998;140:885-95.
24. 24 Serrador JM, Nieto M, Alonso-Lebrero JL et al. CD43 interacts with moesin and ezrin and regulates its redistribution to the uropods of T lymphocytes at the cell-cell contacts. Blood 1998;91:4632-44.
25. 25 Pedraza-Alva G, Merida LB, Burakoff SJ, Rosenstein Y. CD43-specific activation of T cells induces association of CD43 to Fyn kinase. J Biol Chem 1996;271:27564-8.
26. 26 Pedraza-Alva G, Merida LB, Burakoff SJ, Rosenstein Y. T-cell activation through the CD43 molecule leads to Vav tyrosine phosphorylation and mitogen-activated protein kinase pathway activation. J Biol Chem 1998;273:14218-24.
27. 27 Jiang W, Woitach JT, Keil RL, Bhavanandan VP. Bovine submaxillary mucin contains multiple domains and tandemly repeated non-identical sequences. Biochem J 1998;331:193-9.
28. 28 Ligtenberg MJ, Vos HL, Gennissen AM, Hilkens J. Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini. J Biol Chem 1990;265:5573-8.
29. 29 Gendler SJ, Lancaster CA, Taylor-Papadimitriou J et al. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 1990;265:15286-93.
30. 30 Tsuji T, Osawa T. Carbohydrate structures of bovine submaxillary mucin. Carbohydr Res 1986;151:391-402.
31. + T cells. Eur J Immunol 1999;29:809-14.
32. 32 Shimonkevitz R, Colon S, Kappler JW, Marrack P, Grey HM. Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen. J Immunol 1984;133:2067-74.
33. 33 Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 1998;395:82-6.
34. 34 Wild MK, Cambiaggi A, Brown MH et al. Dependence of T cell antigen recognition on the dimensions of an accessory receptorligand complex. J Exp Med 1999;190:31-41.
35. 35 Sasaki K, Okouchi Y, Rothkotter HJP, Abstract R. Three-dimensional distribution of intercellular adhesion molecule-1 on lymphocytes in the high endothelial venule analyzed by backscatter electron imaging. Acta Anat 1998;162:33-9.
36. 36 Itzkowitz SH, Bloom EJ, Kokal WA, Modin G, Hakomori S, Kim YS. Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 1990;66:1960-6.
37. 37 Muramatsu T. Carbohydrate signals in metastasis and prognosis of human carcinomas. Glycobiology 1993;3:291-6.